TXMD: TherapeuticsMD, Inc. Quarterly Revenue Growth

Graphic logo of TherapeuticsMD (TXMD)

TherapeuticsMD, Inc. (TXMD) is optimizing the distribution of women's pharmaceuticals through AI-driven cloud IT solutions, eliminating manual labor. This chart on GURU.Markets displays the quarterly revenue growth rate, where the latest parameter is 61.10. Business stability is underpinned by approved drugs and clinical partnerships, while the current strategy focuses on portfolio management and maximizing royalties during the maturity stage.

TXMD TherapeuticsMD Corp Quarterly Revenue Increase (07/04/2022 - 11/20/2026)

Comprehensive metric breakdowns and analytics for TherapeuticsMD Corp (TXMD)

- stock price and consensus target price:
- cash and cash movement details:
Basic company analysis:TherapeuticsMD - TXMD
Mass-produced product of TherapeuticsMD Inc

This indicator measures the dynamics of quarterly sales volume changes, converting sparse reporting data into a continuous series for volatility analysis and Sharpe ratio calculation. By examining quarterly revenue growth statistics, an investor assesses the financial stability of TherapeuticsMD, Inc. (TXMD), which in this case is based on stable royalty payments from its women's health drug portfolio.